299. Cystic fibrosis Clinical trials / Disease details


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05225805
(ClinicalTrials.gov)
February 15, 20227/1/2022Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic FibrosisA Phase 1, Open-Label, Randomized, Crossover Study to Assess the Safety and Pharmacokinetics Following Single Doses of Oral and Intravenous Xenleta (Lefamulin) in Adult Patients With Cystic FibrosisCystic FibrosisDrug: LefamulinNabriva Therapeutics AGNULLNot yet recruiting18 Years80 YearsAll12Phase 1NULL